sgRNA specifically targeting CLCN7 and application of sgRNA
A specific and targeted technology, which is applied to sgRNA specifically targeting CLCN7 and its application field, can solve the problems of failure to apply benign osteolithiasis and limited effective treatment methods
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0034] Example 1
[0035] This embodiment provides a sgRNA that specifically targets the CLCN7 gene and a recombinant plasmid including the sgRNA.
[0036] The sources of the materials in this embodiment are as follows:
[0037] CRISPR / Cas9 plasmid was purchased from Beijing Saibei Biotechnology Co., Ltd. See the plasmid map figure 1 .
[0038] The competent cell DH5α was purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd.
[0039] BspQ I high-fidelity restriction endonuclease and T4 ligase were purchased from NEB.
[0040] DNA gel recovery kit, plasmid small extraction kit and TOP10 competent cells were purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd.
[0041] The high-fidelity PCR enzyme was purchased from Baori Biotechnology (Beijing) Co., Ltd.
[0042] The DNA primers were provided by Suzhou Jinweizhi Biotechnology Co., Ltd., and the DNA sequencing was completed by Beijing Liuhe Huada Gene Technology Co., Ltd.
[0043] In this embodiment, the preparation m...
Example Embodiment
[0061] Example 2
[0062] The recombinant plasmids CLCN7-sg1RNA-CRISPR / Cas9 and CLCN7-sg2RNA-CRISPR / Cas9 in Example 1 were electrotransformed into mouse embryonic stem cells, and positive clones were obtained after G418 screening.
[0063] Take the mouse embryonic stem cells that have not been transferred into the recombinant plasmid as a control, put the positive cloned cells and the control cells into the cell lysate for lysis, and take the lysate supernatant to amplify the CLCN7 gene.
[0064] The results showed that the length of the amplified fragments of the positive cloned cells was significantly smaller than that of the control cells. The results showed that the recombinant plasmid provided in Example 1 can shear the CLCN7 gene sequence to achieve gene editing.
Example Embodiment
[0065] Example 3
[0066] A composition comprising the recombinant vector in Example 1. The composition can be used to edit the CLCN7 gene and be used for the knockout or modification of the CLCN7 gene.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap